These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8001593)

  • 1. Metabolite profiles of two [14C]-labelled catechol O-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile.
    Wikberg T; Vuorela A
    Eur J Drug Metab Pharmacokinet; 1994; 19(2):125-35. PubMed ID: 8001593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of major metabolites of the catechol-O-methyltransferase inhibitor nitecapone in the rat and dog.
    Wikberg T; Taskinen J
    Drug Metab Dispos; 1993; 21(2):325-33. PubMed ID: 8097704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of major urinary metabolites of the catechol-O-methyltransferase inhibitor entacapone in the dog.
    Wikberg T; Ottoila P; Taskinen J
    Eur J Drug Metab Pharmacokinet; 1993; 18(4):359-67. PubMed ID: 8020535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans.
    Wikberg T; Vuorela A; Ottoila P; Taskinen J
    Drug Metab Dispos; 1993; 21(1):81-92. PubMed ID: 8095232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine.
    Taskinen J; Wikberg T; Ottoila P; Kanner L; Lotta T; Pippuri A; Bäckström R
    Drug Metab Dispos; 1991; 19(1):178-83. PubMed ID: 1673395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-assisted synthesis and structural characterization of nitrocatechol glucuronides.
    Luukkanen L; Kilpeläinen I; Kangas H; Ottoila P; Elovaara E; Taskinen J
    Bioconjug Chem; 1999; 10(1):150-4. PubMed ID: 9893978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of a catechol-O-methyltransferase inhibitor, nitecapone, in human plasma and urine by liquid chromatography.
    Wikberg T; Taskinen J
    J Pharm Biomed Anal; 1991; 9(1):59-64. PubMed ID: 2043724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucuronidation of entacapone, nitecapone, tolcapone, and some other nitrocatechols by rat liver microsomes.
    Lautala P; Kivimaa M; Salomies H; Elovaara E; Taskinen J
    Pharm Res; 1997 Oct; 14(10):1444-8. PubMed ID: 9358559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatographic determination of a new catechol-O-methyltransferase inhibitor, entacapone, and its Z-isomer in human plasma and urine.
    Karlsson M; Wikberg T
    J Pharm Biomed Anal; 1992 Aug; 10(8):593-600. PubMed ID: 1463794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a novel catechol-O-methyltransferase inhibitor, nitecapone, on the metabolism of L-dopa in healthy volunteers.
    Kaakkola S; Gordin A; Järvinen M; Wikberg T; Schultz E; Nissinen E; Pentikäinen PJ; Rita H
    Clin Neuropharmacol; 1990 Oct; 13(5):436-47. PubMed ID: 2272023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitecapone: a nitric oxide radical scavenger.
    Marcocci L; Maguire JJ; Packer L
    Biochem Mol Biol Int; 1994 Oct; 34(3):531-41. PubMed ID: 7833830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micellar electrokinetic capillary chromatography method for direct determination of glucuronides of entacapone and its (Z)-isomer in human urine.
    Lehtonen P; Lehtinen S; Mälkki-Laine L; Wikberg T
    J Chromatogr A; 1999 Mar; 836(1):173-88. PubMed ID: 10220913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1-like dopamine receptor activation and natriuresis by nitrocatechol COMT inhibitors.
    Vieira-Coelho MA; Gomes P; Serrão MP; Soares-da-Silva P
    Kidney Int; 2001 May; 59(5):1683-94. PubMed ID: 11318939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The equine metabolism of the catechol-O-methyltransferase enzyme inhibitor nitecapone.
    Stanley S; Deng D; Van den Berg K; Foo HC
    Drug Test Anal; 2022 May; 14(5):929-935. PubMed ID: 34545698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W; Erlaçin S; Frankus E; Uragg H
    Arzneimittelforschung; 1981; 31(11):1932-43. PubMed ID: 7198474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of nitecapone and (13C6)nitecapone in human plasma by gas chromatography/mass spectrometry.
    Ottoila P; Pakkala E; Karlsson C; Taskinen J
    Biol Mass Spectrom; 1991 Dec; 20(12):771-6. PubMed ID: 1812986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nitecapone (OR-462) on the pharmacokinetics of levodopa and 3-O-methyldopa formation in cynomolgus monkeys.
    Cedarbaum JM; Léger G; Reches A; Guttman M
    Clin Neuropharmacol; 1990 Dec; 13(6):544-52. PubMed ID: 2276119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise hemodynamics and catecholamine metabolism after catechol-O-methyltransferase inhibition with nitecapone.
    Sundberg S; Scheinin M; Ojala-Karlsson P; Kaakkola S; Akkila J; Gordin A
    Clin Pharmacol Ther; 1990 Oct; 48(4):356-64. PubMed ID: 2225697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism and excretion of 3-O-methyl-(+)-catechin in the rat, mouse, and marmoset.
    Hackett AM; Griffiths LA
    Drug Metab Dispos; 1981; 9(1):54-9. PubMed ID: 6111433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.